PAVmed Inc. — Investor Relations & Filings
Filings indexed
648
across all filing types
Latest filing
2026-05-15
Regulatory Filings
Country
US
United States of America
Listing
US
PAVM
PAVmed Inc. is a commercial-stage, diversified medical technology company that develops and commercializes products across the medical device, diagnostics, and digital health sectors. The company operates through a shared-services business model to support its majority-owned subsidiaries. Its key subsidiary, Lucid Diagnostics, offers the EsoGuard® Esophageal DNA Test, a diagnostic tool for the early detection of esophageal precancer. Another subsidiary, Veris Health, provides a digital health platform for remote patient monitoring to enhance personalized cancer care. PAVmed's strategy focuses on acquiring and developing early-stage medical technologies to address unmet clinical needs for patients and healthcare systems.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 8-K | 2026-05-15 | English | |
| FORM 10-Q | 2026-05-14 | English | |
| DEF 14A - PAVmed Inc. (0001624326) (Filer) | 2026-05-01 | English | |
| ARS - PAVmed Inc. (0001624326) (Filer) | 2026-04-30 | English | |
| 8-K - PAVmed Inc. (0001624326) (Filer) | 2026-03-30 | English | |
| 10-K - PAVmed Inc. (0001624326) (Filer) | 2026-03-27 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
10 filings
| |||||
| 46353959 | 8-K | 2026-05-15 | English | ||
| 46274924 | FORM 10-Q | 2026-05-14 | English | ||
| 39513629 | DEF 14A - PAVmed Inc. (0001624326) (Filer) | 2026-05-01 | English | ||
| 39226382 | ARS - PAVmed Inc. (0001624326) (Filer) | 2026-04-30 | English | ||
| 33087941 | 8-K - PAVmed Inc. (0001624326) (Filer) | 2026-03-30 | English | ||
| 33066223 | 10-K - PAVmed Inc. (0001624326) (Filer) | 2026-03-27 | English | ||
| 32895374 | DEF 14A - PAVMED INC. (0001624326) (Filer) | 2026-02-24 | English | ||
| 30985373 | D Filing | 2026-02-17 | English | ||
| 30985374 | 8-K Filing | 2026-02-04 | English | ||
| 30985393 | 8-K Filing | 2026-01-23 | English | ||
|
2025
5 filings
| |||||
| 12828356 | 8-K | 2025-12-30 | English | ||
| 12828357 | 8-K | 2025-12-05 | English | ||
| 12828358 | 8-K | 2025-11-13 | English | ||
| 12828359 | 10-Q | 2025-11-12 | English | ||
| 12828360 | DEF 14A | 2025-10-31 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
CHAMPIONS ONCOLOGY, INC.
A CRO providing end-to-end solutions to accelerate oncology…
|
CSBR | US | Professional, scientific and te… |
|
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
A contract research organization supporting drug discovery …
|
CRL | US | Professional, scientific and te… |
|
ChemPartner PharmaTech Co., Ltd.
Global CRO and CDMO providing integrated drug discovery and…
|
300149 | CN | Professional, scientific and te… |
|
CHIMERIC THERAPEUTICS LIMITED
Clinical-stage cell therapy company developing CAR T and NK…
|
CHM | AU | Professional, scientific and te… |
|
China National Electric Apparatus Research Institute Co., Ltd.
R&D institution for electrical and electronics testing, equ…
|
688128 | CN | Professional, scientific and te… |
|
Chiome Bioscience Inc.
Clinical-stage biotech company developing antibody-based th…
|
4583 | JP | Professional, scientific and te… |
|
CHITOGENX INC
Clinical stage regenerative medicine company focused on nov…
|
CHGX | CA | Professional, scientific and te… |
|
Chordate Medical Holding AB
Develops a patented, drug-free neuromodulation treatment fo…
|
CMH | SE | Professional, scientific and te… |
|
Chordia Therapeutics,Inc
Clinical-stage biotech developing novel cancer therapies ta…
|
190A | JP | Professional, scientific and te… |
|
Cibus, Inc.
Develops and licenses plant traits using non-GMO precision …
|
CBUS | US | Professional, scientific and te… |
PAVmed Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/35221/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=35221 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=35221 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=35221 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 35221}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for PAVmed Inc. (id: 35221)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.